Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension

Clinical trial NCT00872170 · COMPLETED

Trial details

NCT number: NCT00872170
Sponsor: Carelon Research
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Thalassemia Hypertension, Pulmonary

Start date: 2009-03-01
Primary completion: 2010-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.